Specifically, DJ-1 has been shown to inhibit the expression of PTEN, a well-recognized tumor suppressor, thereby enhancing the activation of the PI3K/AKT pathway and promoting cancer cell survival and proliferation [127]. The gene discussed is AKT1; the disease is neoplasm.